Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02718352 · ClinicalTrials.gov registry record
A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 8
- Enrollment target
NCT02718352 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 8 participants.
The verdict
NCT02718352 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
Many buprenorphine treatment programs do not have services dedicated to adolescents and young adults. As a precursor to developing and evaluating an adolescent and young adult buprenorphine treatment program at APT Foundation Inc, we propose to conduct a 1 year prospective study of 16 to 25 year old treatment-seeking individuals enrolled in the APT Adolescent and Young Adult Suboxone Program
Interventions
- OTHER Naturalistic Prospective Cohort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02718352
The ClinicalTrials.gov registry entry for NCT02718352 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Naturalistic Prospective Cohort is the first listed.
NCT02718352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02718352 about?
NCT02718352 is a clinical study titled "A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence". Many buprenorphine treatment programs do not have services dedicated to adolescents and young adults. As a precursor to developing and evaluating an adolescent and young adult buprenorphine treatment program at APT Foundation Inc, we propose to conduct a 1 year prospective study of 16 to 25 year old...
What is the current status of trial NCT02718352?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2016-03. Estimated completion is 2018-03.
What interventions are being tested in trial NCT02718352?
The interventions under investigation include: Naturalistic Prospective Cohort (OTHER).
Who is sponsoring clinical trial NCT02718352?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.